Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Minarik

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cancer Genomics & Proteomics|February 19, 2022
Combination of Circulating Tumour DNA and <sup>18</sup>F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective StudyOndrej Fiala, Jan Baxa, Martin Svaton, et al.
Anticancer Research|April 30, 2016
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with ErlotinibOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research|October 25, 2017
Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLCOndrej Fiala, Petr Hosek, Milos Pesek, et al.
Human Mutation|June 12, 2014
Toward male individualization with rapidly mutating y-chromosomal short tandem repeatsKaye N Ballantyne, Arwin Ralf, Rachid Aboukhalid, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cancer Genomics & Proteomics|February 19, 2022
Combination of Circulating Tumour DNA and <sup>18</sup>F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective StudyOndrej Fiala, Jan Baxa, Martin Svaton, et al.
Anticancer Research|April 30, 2016
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with ErlotinibOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research|October 25, 2017
Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLCOndrej Fiala, Petr Hosek, Milos Pesek, et al.
Human Mutation|June 12, 2014
Toward male individualization with rapidly mutating y-chromosomal short tandem repeatsKaye N Ballantyne, Arwin Ralf, Rachid Aboukhalid, et al.
Pageof 6